Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $13.31 million as of October 31, 2025. Its market cap has decreased by -94.03% in one year.

Market Cap

13.31M

Enterprise Value

35.92M

Revenue

65.09M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 13.31M, a decrease of -98.91%. That is a compound annual growth rate of -34.99%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	13.31M	-90.35%
Dec 31, 2024	137.84M	-23.47%
Dec 29, 2023	180.11M	-24.70%
Dec 30, 2022	239.19M	-59.17%
Dec 31, 2021	585.77M	-29.79%
Dec 31, 2020	834.26M	561.07%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Federal National Mortgage Association	58.59B
Federal Home Loan Mortgage	30.70B
Oicintra	5.16B
Central Bancompany	4.49B
First National of Nebraska	3.80B
Alpine Auto Brokers	3.60B
Semnur Pharmaceuticals	2.63B
Wilson Bank Holding Company	2.12B

Market Cap Rankings